VREOF
Vireo Growth Inc.
OTC · CIK 1771706
Last close9.49
Daily change-0.36 (-3.65%)
10 Years gain-93.03%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
VREOF · STANDARD
SIC 2834 · Pharmaceutical Preparations · Fiscal year end 1231
Fundamental
71.1Momentum
0.0Acceleration
0.0Confidence
83.0Annual Revenue6
Quarterly Revenue20
Annual CFO6
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth19.1 / 25
Quality18.7 / 25
Capital Efficiency7.8 / 20
Balance Sheet12.1 / 15
Shareholder Economics8.5 / 10
Forward Indicators5.0 / 5
Signals
Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 87.7081%.
Warnings
Inventory anomaly · MEDIUMInventory growth is materially above revenue growth.
Gross margin compression · MEDIUMGross margin compressed by 4.4497 percentage points.
Operating margin compression · MEDIUMOperating margin compressed by 16.2625 percentage points.
Possible growth trap · HIGHRevenue growth is high, but quality indicators are deteriorating.
Key Metrics
Revenue Growth TTM360.5%OK
Revenue CAGR 3Y53.28%OK
Gross Margin46.65%OK
Operating Margin0.33%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC0.84%OK
Incremental Operating Margin 3Y4.18%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-87.71%OK
SBC / Revenue4.94%OK
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $268.77M | $127.10M | -$1.05M | $3.71M | -$24.61M | 47.29% | -0.39% | -9.16% | -1.12% | 734.74M |
| 2025 FY Dec 31, 2024 | $99.38M | $50.77M | $13.56M | -$10.23M | -$21.93M | 51.09% | 13.65% | -22.07% | n/a | 180.39M |
| 2024 FY Dec 31, 2023 | $88.13M | $44.10M | $10.58M | -$965,906.00 | -$5.93M | 50.04% | 12% | -6.73% | 116.8% | 135.24M |
| 2023 FY Dec 31, 2022 | $74.63M | $30.91M | -$6.94M | -$18.07M | -$23.63M | 41.42% | -9.3% | -31.67% | -10.8% | 128.13M |
| 2022 FY Dec 31, 2021 | $54.45M | $19.80M | -$20.48M | -$30.52M | -$48.56M | 36.36% | -37.62% | -89.19% | -35.35% | 123.81M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $455.26M | sum latest 4 fiscal quarters Revenue | OK | 0001104659-26-097118, 0001104659-25-110364 |
| Revenue Growth TTM | 360.5% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001104659-26-097118, 0001104659-25-110364 |
| Revenue CAGR 3Y | 53.28% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001104659-26-029561 |
| Revenue CAGR 5Y | 40.43% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001104659-26-029561 |
| Gross Profit CAGR 3Y | 60.21% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001104659-26-029561 |
| Operating Income Growth | -90.8% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001104659-26-097118, 0001104659-25-110364 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 46.65% | Gross Profit / Revenue | OK | 0001104659-26-097118, 0001104659-25-110364 |
| Operating Margin | 0.33% | Operating Income / Revenue | OK | 0001104659-26-097118, 0001104659-25-110364 |
| ROIC | 0.84% | NOPAT / Average Invested Capital | OK | 0001104659-26-097118, 0001104659-25-110364 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001104659-26-097118 |
| Current Ratio | 1.01x | Current Assets / Current Liabilities | OK | derived |
| SBC / Revenue | 4.94% | SBC / Revenue | OK | 0001104659-26-097118, 0001104659-26-059455 |
| Revenue per Diluted Share | $10.10 | Revenue / Diluted Shares | OK | 0001104659-26-097118, 0001104659-25-110364 |